DACHSER has undergone good distribution practice (GDP) audits at its sites in Frankfurt, Madrid, Barcelona, and Mumbai, as well as at the Head Office in Kempten. An independent institute certified that DACHSER complies with the specifications relating to safe and secure transport chains in the pharmaceutical sector.
With the good distribution practice (GDP) certification, an external authority has vouched for DACHSER’s compliance with strict quality criteria and its performance in life science and healthcare logistics. The logistics provider is receiving the certificate for its global quality management system and its strategic locations in Germany, Spain, and India. This certificate verifies that shipments in DACHSER’s Life Science and Healthcare network are handled in accordance with EU regulations.
Life science and healthcare products are subject to strict requirements during transport, storage, and handling. There are extensive regulations to observe, and customer, legal, and product specifications must be met. Medication, vaccines, and other pharmaceuticals are often temperature- and time-sensitive shipments that require GDP compliance. As an acknowledged industry standard, GDP-compliant certification attests to these products’ safe handling and proper transportation. “This certification is a mark of quality for our global DACHSER Life Science and Healthcare network,” says Timo Stroh, Head of Global Air Freight at DACHSER. “In this way, we do our part to ensure safe and secure supply chains for our customers in the life science and healthcare industry.”
อัพเดตข่าวสารและบทความที่น่าสนใจในอุตสาหกรรมโลจิสติกส์ก่อนใคร ผ่าน Line Official Account @Airfreight Logistics เพียงเพิ่มเราเป็นเพื่อน @Airfreight Logistics หรือคลิกที่นี่
